She used it as a "medicine" to fight against inflammation
Huadong Medicine's polycaprolactone microsphere facial filler for injection obtained medical device registration certificate
PLOS Med: Antiemetic, analgesic, anti-inflammatory... Analysis of the safety and tolerability of medicinal cannabinoids
For thousands of years, the cannabis plant has been used for recreational and medicinal purposes throughout the world
"The Lancet Respiratory Medicine" first published the results of the Chinese original third
State Council Information Office: Seven key tasks of Chinese medicine in the "14th Five-Year Plan"!
State Council Information Office: Seven key tasks of Chinese medicine in the "14th Five-Year Plan"!
The release of major Chinese medicine documents affects all pharmaceutical companies...
"14th Five-Year Plan" will build 30 national traditional Chinese medicine inheritance and innovation centers
State Administration of Traditional Chinese Medicine: Establishment of a treatment department in Chinese medicine hospitals above the second level
guidelines (trial)", "Nano-medicine non-clinical safety evaluation research technical guidelines (trial
69 medicines, which are under the key monitoring and focus of medical insurance (list attached)
The blockbuster policy of Chinese medicine is coming, and the entire chain of listed chains has become popular
Huadong Medicine Class 1 biopharmaceutical IMGN853 was approved for clinical use
On March 30, the Sino-US East China Class 1 biopharmaceutical IMGN853 (Mirvetuximab Soravtansine), a subsidiary of East
Nature medicine: Pay attention to COVID-19 post-acute syndrome
SARS-CoV-2 is
The European Medicines Agency accepts the marketing authorization application (MAA) of Enfortumab Vedotin
The Ministry of Education announces the enrollment plan for undergraduate clinical medicine students in China
Time of Update: 2021-04-13
MAA's approval is based on the global Phase III EV-301 trial, which evaluated the efficacy of enfortumab vedotin in the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received platinum-based chemotherapy and PD-1/L1 inhibitors.
Time of Update: 2021-04-13
2. Colleges and universities that are included in the list of undergraduate clinical medicine (English-taught) international students in China for the 2021-2022 academic year must continue to recruit students strictly in accordance with the spirit of the "Notice".